Keywords: teva, aims, strengthen, its, core, generics, business

Teva aims to strengthen its core generics business, new CEO tells

Article | 20 May 2002

Print This

Israeli drug firm Teva's core business is generics, and this is the areain which it intends to maintain and strengthen ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in